|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Peripheral chemoreceptor function has been tested using either
the hyperoxic test (HT), which decreases minute ventilation (
E)
by causing physiologic chemodenervation, or the alternate breath
test (ABT), which induces
E alternations by delivering rapid hypoxic stimuli through breath-by-breath alternations in fractional
inspired O2 between normoxia (0.21) and hypoxia (0.15). No previous studies have compared ventilatory responses to both tests in
the same infants. We hypothesized that the
E decrease during HT
would be significantly related to
E alternations during ABT. Eighteen infants (postnatal age 21 ± 14 d) underwent two 30-s HTs
and two ABTs (quiet sleep, face mask, and pneumotachograph; mass spectrometry measurement of inspired and expired O2 and
CO2 fractions; and breath-by-breath analysis). The tests were done in random order. Decreases in
E and mean inspiratory flow (tidal volume over inspiratory time, VT/TI) during HTs were significantly correlated to their respective percentage coefficients of alternation during ABTs (r = 0.69 and 0.70, respectively, p < 0.01). Principal components analysis showed that the
E and VT/TI decreases
during HTs were due chiefly to a fall in VT, whereas
E and VT/TI alternations were ascribable to alternations in both VT and TI. Intraindividual coefficients of variation of
E changes were significantly lower during HTs than during ABTs. We conclude that (1)
ventilatory responses to HT and ABT are significantly correlated
despite differences in the mechanisms of the
E changes; (2) the
better reproducibility of the
E response to HT as compared with
ABT may be an advantage in clinical practice.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: breathing control; mass spectrometry; peripheral chemoreceptors
Peripheral chemoreceptor function protects the body against changes in arterial PO2. Peripheral chemoreceptors are active in utero (1), although in mammals their PO2 threshold is reset to a higher level after birth (2, 3). The peripheral chemoreceptor component of ventilatory drive is thought to play a major role during the development of breathing control (4). Defective peripheral chemoreceptor function may contribute to sudden infant death syndrome (4). Therefore, testing peripheral chemoreceptor function may be clinically useful in infants. The first test described in the literature was the hyperoxic test (HT) (5). The alternate breath test (ABT) was developed more recently (2, 6).
The HT examines peripheral chemoreceptor function by
measuring the decrease in minute ventilation (
E) caused by
hyperoxia as compared with normoxia (7). In an earlier
study (13), we defined the HT response time as the time from
hyperoxia onset to the first significant
E drop during a 30-s
HT and found that calculating the ventilatory response at the
response time provided a reproducible assessment of peripheral chemoreceptor function. The
E drop was associated
with a significant decrease in tidal volume (VT), but not in respiratory frequency (13).
The ABT delivers rapid, alternating hypoxic stimuli to the
peripheral chemoreceptors through breath-by-breath alternations in fractional inspired O2 between normoxia and hypoxia
(2). The ventilatory response is assessed by looking for significant alternations in
E and in all its components, including
VT, flows, and timing variables. Bilateral section of the carotid
sinus nerve significantly reduces the ventilatory response to
ABT in lambs, indicating that the respiratory variable alternations are produced mainly by a reflex arising from the peripheral
chemoreceptors (14). ABT is a reproducible test of peripheral
chemoreceptor function under standardized conditions in infants (15).
No previous studies have compared the ventilatory responses to both HT and ABT in the same infants or newborn
animals. The present study compared the ventilatory responses
to both tests in a group of 18 infants. Because both tests are
believed to reflect the strength of the peripheral chemoreceptor drive, we hypothesized that the
E drop during HT would
be significantly related to
E alternations during ABT. We examined the changes in respiratory variables underlying
E
changes during HT and ABT. Furthermore, we compared the
reproducibility of HT and ABT by performing both tests twice
during the same session in the study infants.
| |
METHODS |
|---|
|
|
|---|
Subjects
Eighteen infants were studied (mean gestational age, 36.6 ± 3.3 wk [range, 30 to 41]; mean postnatal age, 21 ± 14 d [range, 2 to 61]; mean body weight at time of study, 3.1 ± 0.9 kg [range, 1.9 to 5.0]). They were not healthy control infants. Of the 12 full-term infants, three had intrauterine growth retardation, two were born to diabetic mothers, and seven had neonatal infection. The remaining six infants were preterm; three had respiratory distress syndrome, which was managed by oxygen during the first 3 d, without mechanical ventilation. All 18 infants were free from neurologic, cardiac, and respiratory symptoms at testing. The parents gave their informed consent to participation of their infants in the study.
Protocol
A standardized protocol was used (13, 15). Tests were done during quiet sleep in unsedated infants (16). A face mask attached to a pneumotachograph was used (17). Each study infant underwent two successive HTs and two successive ABTs at intervals of 2 min, in random order. Each HT lasted 1 min and consisted of a 30-s normoxic control period, during which infants breathed room air, followed by a 30-s hyperoxic period, during which infants inspired 100% of O2 from a bag and expired to room air (13). Each ABT lasted 4 min and included a 2-min control run (CR), during which ventilation alternated from a breath to a breath between ambient air and ambient air, followed by a 2-min test run (TR), during which breath-by-breath alternations were between ambient air and 15% O2 (15).
Equipment
The experimental setup allowed measurement of respiratory flow, determination of O2 and CO2 fractional concentrations, and use of a fast respiratory valve to deliver gas mixtures during the HTs and ABTs (13, 15). Oxygen saturation was monitored throughout the tests.
Data Analysis
Respiratory flow was integrated for breath-by-breath measurements
of the following respiratory variables: VT, inspiratory time (TI), expiratory time (TE), total respiratory cycle duration (Ttot), respiratory
frequency (f), duty cycle (TI/Ttot),
E, and mean inspiratory flow
(VT/TI). Inspired (FIO2, FICO2) and end-tidal (FETO2, FETCO2) fractions
of O2 and CO2 were detected breath-by-breath. Numerical criteria
were used to discard nonrepresentative breaths from HT and ABT
calculations (13, 15). Ventilatory responses to HT (13) and ABT (3, 15)
were determined as previously described.
Comparison of the Ventilatory Responses to HT and ABT
Correlation.In each infant and for each respiratory variable, we averaged the changes determined during the two HTs and the percentage alternation coefficients during the two ABTs. Only those respiratory variables that showed significant changes during both HTs and ABTs were used to compute the correlation coefficients and linear relationships between HT and ABT.
Principal components analysis (PCA).Only respiratory variables that showed significant changes during both HT and ABT were used for PCA (18).
Reproducibility of the ventilatory response.Interindividual and intraindividual coefficients of variation (CV) of the mean percentage alternation coefficients were computed during the two ABTs and of the changes in respiratory variables during the two HTs.
| |
RESULTS |
|---|
|
|
|---|
Average SaO2 was 97 ± 1% at baseline and 95 ± 2% during ABT, a nonsignificant difference. SaO2 remained above 92% during ABT in all infants. Minute ventilation and inspired and end-tidal gas fractions of O2 and CO2 in normoxia are given in Table 1 for the two HTs and the two ABTs. No significant differences were observed between normoxic conditions. Mean percentage of nonrepresentative breaths was 1.9% ± 0.6% and 1.7% ± 0.9% during ABTs and HTs, respectively.
|
Ventilatory Response to HT
During both HTs, all infants showed significant decreases in
E, VT, and VT/TI. When the data were pooled over infants,
E, VT, TI, and VT/TI exhibited significant percentage changes
during both HT1 and HT2 (Table 2). When HT1 and HT2
were compared, no significant differences were found among
changes in these respiratory variables. Neither were any significant changes seen during HTs for TE, Ttot, TI/Ttot, or f
(Table 2).
|
Ventilatory Response to ABT
In all infants, mean percentage alternation coefficients in TR were significantly different from those of CR during both ABTs. For pooled data over infants, Table 2 shows mean percentage alternation coefficients of all respiratory variables in the TRs of ABT1 and ABT2. No significant differences were found between ABT1 and ABT2.
Comparison of HT and ABT
Correlation.
The mean
E decrease over the two HTs was linearly related to the corresponding mean percentage alternation coefficient over the two ABTs (r = 0.69, p < 0.01) (Figure
1A). A significant relationship was also found for VT/TI (r = 0.70, p < 0.01) (Figure 1B). No significant correlations were
found for changes in VT and TI during HT and ABT.
|
Principal component analysis. PCA was applied to the respiratory variables that changed significantly during both HT and ABT. Figure 2 shows individual location of respiratory variables in a principal component space. VT/TI (HT) (factor loading = 0.87) and VT (HT) (factor loading = 0.85) determined axis 1. VT (ABT) (factor loading = 0.88) and TI (ABT) (factor loading = 0.86) determined axis 2. Thus, respiratory variables that collected much of the information were VT/TI and VT in HT and VT and TI in ABT.
|
Reproducibility.
Mean intraindividual and interindividual
CVs for changes in
E, VT, TI, and VT/TI during HT and ABT
are shown in Table 3. Intraindividual CVs for
E, VT, and VT/TI
were significantly lower for HT than for ABT (p < 0.01). Interindividual CVs of changes in
E and VT showed large and similar values for both HT and ABT. Interindividual CVs of changes
in TI and VT/TI were greater during HT than during ABT.
|
| |
DISCUSSION |
|---|
|
|
|---|
The aim of the present study was to compare ventilatory responses to HT and ABT in infants. Because both tests are believed to reflect peripheral chemoreceptor function, we hypothesized that the ventilatory responses they elicit should be related to each other. We found that
E and VT/TI decreases during HT
were significantly related to the corresponding percentage alternation coefficients during ABT. PCA showed that the
E
decrease during HT was mainly explained by the fall in VT and
that the
E alternations during ABT were explained by alternations in both VT and TI. Intraindividual CV of
E changes
were significantly lower during HT than during ABT.
Subjects and Measurement Conditions
Our study infants were not healthy control infants. Therefore,
our study does not provide normative data on ventilatory responses to HT and ABT. However, because all study infants
exhibited a significant response to HT and ABT, our data allowed us to compare ventilatory responses to both tests. The
study objective was to compare ventilatory responses to HT
and ABT performed in random order in the same infants.
Therefore, we used an experimental setup involving breath-by-breath quantitative measurement of respiratory variables
and gas fractions. This required application of a face mask attached to a pneumotachograph. Face-mask application disrupts the breathing pattern for 10 to 40 s (19). Consequently,
we started HTs and ABTs at least 1 min after face-mask application. FICO2 remained below 0.3%, indicating that there was
probably no sustained elevation in
E caused by CO2 rebreathing (Table 1). That ABT is safe has been established in
earlier studies (6, 15, 20) and was confirmed in our study. A
risk of retinopathy associated with exposure to high concentrations of oxygen has been reported in preterm infants weighing less than 1,200 g (21). All our study infants weighed far
more than 1,200 g.
Hyperoxic Test
HTs in infants have been performed using various durations
of O2 inhalation, ranging from one or two breaths (7, 8) to 30 s
(9). However, one or two breaths of O2 inhalation may not
be sufficient to ensure complete elimination of peripheral chemoreceptor input (22). We used O2 inhalation for 30 s.
Furthermore, we measured the ventilatory response to HT using breath-by-breath analysis at the response time, defined as
the time from HT onset to the first significant
E change. In
an earlier study (13), we showed that the ventilatory response
at the response time was significantly greater than the mean
percentage
E change over a 30-s HT (13). Ventilatory response at the response time is thought to be dependent only on
suppression of the peripheral chemoreceptor drive, whereas
the mean percent decrease over 30 s reflects both the initial
drop caused by physiologic chemodenervation and the early
phase of the subsequent increase in ventilation related to the
metabolic response to hyperoxia in infants (23).
Alternate Breath Test
In previous studies in infants, breath-by-breath alternations in fractional inspired O2 were delivered through a nasal catheter, and respiratory responses were measured noninvasively using an uncalibrated inductive plethysmograph, a setup that does not allow measurement of inspired and end-tidal gases (6, 20, 24). With our experimental setup, in contrast, we were able to measure inspired and end-tidal O2 and CO2 gas fractions. The constancy of FETCO2 during ABT in our study shows that normocapnia was maintained. We verified that FIO2 remained within a narrow range during each alternate hypoxic breath, and we removed from the raw data all TR breaths that had an FIO2 greater than 0.17 because of defective computer detection of the end of expiration. The FETO2 recordings showed stable FETO2 oscillations reflecting the alternating peripheral chemoreceptor stimulation. The ABT repeatedly delivers a hypoxic stimulus to the peripheral chemoreceptors over a large number of breaths, allowing averaging of the response. Our study infants exhibited significant ventilatory responses to ABT, including alternations in VT, mean inspiratory flow, and timing variables, as previously reported in a smaller group of infants (15).
Comparison of the HT and the ABT
The experimental setup involving breath-by-breath quantitative measurement of respiratory variables and gas fraction
measurements allowed us to compare ventilatory responses to
HT and ABT performed in random order in the same infants.
The results showed significant correlations between HT and
ABT for
E and VT/TI changes. These data support our hypothesis that two tests believed to reflect peripheral chemoreceptor function should elicit significantly related ventilatory
responses despite opposite effects on peripheral chemoreceptor output to inspiratory drive. PCA corroborated our previous data by showing that the
E and VT/TI decreases seen during hyperoxia were due mainly to a VT decrease (13). Hyperoxia had no effect on f and a slight but significant effect on
TI. In contrast, ABT is known to induce significant alternations in all timing variables, as well as in VT and flows (15). In
the present study, PCA showed that the alternations in
E
and VT/TI were ascribable to alternations in both VT and TI.
The hypoxic stimulus delivered during ABT modifies both VT
and the duration of inspiration. The effect of hypoxia on respiratory timing has been shown to be mediated in large part by
the peripheral chemoreceptors (25).
Our study is the first to compare the reproducibility of ventilatory responses to HT and ABT during a single session in
the same infants. In keeping with previous studies on different
populations (13, 15), the present study showed that intraindividual variability of the ventilatory responses was lower during HT than during ABT (13, 15). Intraindividual CV of the
E drop during HT was half the CV of
E alternations during
ABT in the study infants. This finding suggests that the HT
may be the best test in clinical practice, especially to follow infants with deficient peripheral chemoreceptor function (26).
However, interindividual CV showed large values for the
E
drop during HT and the
E alternations during ABT. The interindividual variability in ABT in our study population was
within the range previously reported in healthy infants, although these were exposed to a broader range of inspired O2
fraction alternations than the infants in the present study (27).
It is unlikely that the large interindividual variability was
related to measurements conditions because we used standardized protocols (13, 15). Rather, differences in peripheral
chemosensitivity may contribute to the substantial interindividual variability of the
E change during both tests (28). This
variability may be a limitation for testing peripheral chemoreceptor function. Nevertheless, both tests have been found effective in demonstrating deficient peripheral chemoreceptor
function in infants with bronchopulmonary dysplasia as compared with control preterm infants (12, 24). However, it may
be difficult to test peripheral chemoreceptor function in infants with abnormal lungs. During ABT, poor alveolar gas
mixing may prolong the time interval between the onset of inspired gas alternation and the occurrence of stable FETO2 oscillations, thereby resulting in nonsignificant ventilatory alternations during ABT. Poor alveolar gas mixing would also be
expected to limit the usefulness of HTs. Breath-by-breath
analysis during a 30-s HT has the advantage of allowing determination of the response time even in infants with abnormal
lung function (12).
In conclusion, we showed for the first time that ventilatory
responses to HT and ABT as assessed based on
E and VT/TI
changes are significantly correlated with each other, although
the mechanisms underlying the
E changes during the two
tests are different. However, the
E change during HT had
only half the variability of the
E change during ABT, suggesting that HT may be more useful in clinical practice.
Chemoreceptor dysfunction has been suggested as a risk factor for sudden infant death syndrome (4). Environmental factors such as perinatal hypoxia (2) have been reported to impair peripheral chemoreceptor function. Consequently, a
reproducible test of chemoreceptor function may be useful in
investigating the control of breathing in high-risk infants (29).
| |
Footnotes |
|---|
Correspondence should be addressed to Claude Gaultier, Service de Physiologie, Hôpital Robert Debré, Université Paris VII, 48, Bd Sérurier, 75019 Paris, France. E-mail: claude.gaultier{at}rdb.ap-hop-paris.fr
(Received in original form September 20, 2000 and accepted in revised form August 21, 2001).
Requests for reprints should be addressed to Belkacem Bouferrache, URAPC (EA 2088) School of Medicine, 3, rue des Louvels, Amiens 80036, France. E-mail: urapc{at}libertysurf.frAcknowledgments: Supported by grants from the Conseil Régional de Picardie, the Institut National de la Santé et de la Recherche Médicale (E9935), and the Université Paris VII.
| |
References |
|---|
|
|
|---|
1.
Blanco CE,
Dawes GS,
Hanson MA,
McCooke HB.
The response to hypoxia of arterial chemoreceptors in fetal sheep and newborn lambs.
J
Physiol (Lond)
1984;
351:
25-37
2.
Hertzberg T,
Hellström S,
Lagercrantz H.
Development of the arterial
chemoreflex and turnover of carotid body catecholamines in the newborn rat.
J Physiol (Lond)
1990;
425:
211-225
3.
Hanson MA,
Kumar P,
Williams BA.
The effect of chronic hypoxia
upon the development of respiratory chemoreflexes in the newborn
kitten.
J Physiol (Lond)
1989;
411:
563-574
4. Hanson MA, Calder N, Watanabe T, Kumar P. The drive to breathe and infant death syndrome. Acta Paediatr 1993; 92: 47-49 .
5.
Dejours P.
Chemoreflexes in breathing.
Physiol Rev
1962;
42:
335-358
6.
Williams BA,
Smyth J,
Boon AW,
Hanson MA,
Kumar P,
Blanco CE.
Development of respiratory chemoreflexes in response to alternations
of fractional inspired oxygen in the newborn infant.
J Physiol (Lond)
1991;
442:
81-90
7. Wilkie RA, Bryan MH, Gaston S, Bryan AC. Maturation of peripheral chemoreceptors in normal newborn infants. Fed Proc 1987; 46: 823 .
8. Parks YA, Beardsmore CS, MacFadyen UM, Pallot DJ, Goodenough PC, Carpentier R, Simpson H. The effect of a single breath of 100% oxygen on breathing in infants at 1, 2, and 3 months of age. Am Rev Respir Dis 1991; 144: 141-145 [Medline].
9. Fagenholz SA, O'Connell K, Shannon DC. Chemoreceptor function and sleep state in apnea. Pediatrics 1976; 58: 31-36 [Abstract].
10.
Hertzberg T,
Lagercrantz H.
Postnatal sensitivity of the peripheral
chemoreceptors in newborn infants.
Arch Dis Child
1987;
62:
1238-1241
11. Katz-Salamon M, Lagercrantz H. Hypoxic ventilatory defence in very preterm infants: attenuation after long term oxygen treatment. Arch Dis Child 1994; 70: F90-F95 .
12. Katz-Salamon M, Jonsson B, Lagercrantz H. Blunted peripheral chemoreceptor response to hyperoxia in a group of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 20: 101-106 [Medline].
13.
Bouferrache B,
Filtchev S,
Leke A,
Marbaix-Li Q,
Freville M,
Gaultier C.
The hyperoxic test in infants reinvestigated.
Am J Respir Crit Care
Med
2000;
161:
160-165
14. Williams BA, Hanson MA. Role of the carotid chemoreceptors in the respiratory response of newborn lambs to alternate pairs of breaths of air and a hypoxic gas. J Dev Physiol 1990; 13: 157-164 [Medline].
15. Bouferrache B, Krim G, Marbaix-Li Q, Freville M, Gaultier C. Reproducibility of the alternating breath test of fractional inspired O2 in infants. Pediatr Res 1998; 44: 239-246 [Medline].
16. Prechtl HFR. The behavioural states of the newborn infant (a review). Brain Res 1974; 76: 185-212 [Medline].
17. Stocks J, Beardsmore CS, Helms P. Infant lung function: measurement conditions and equipment. Eur Respir J 1989; 2: 123S-129S .
18. Benigni R, Giuliani A. Quantitative modeling and biology: the multivariate approach. Am J Physiol (Regulatory Interactive Comp Physiol 35) 1994; 266: R1697-R1704 .
19. Katz-Salamon M, Hertzberg T, Lagercrantz H. CO2-sensitivity in newborn and young infants tested by the rebreathing method. Biol Neonate 1991; 59: 126-132 [Medline].
20. Calder NA, Williams BA, Kumar P, Hanson MA. The respiratory response of healthy term infants to breath-by-breath alternations in inspired oxygen at two postnatal ages. Pediatr Res 1994; 35: 321-324 [Medline].
21.
Lee SK,
Normand C,
McMillan D,
Ohlsson A,
Vincer M,
Lyons C.
for
the Canadian Neonatal Network. Evidence for changing guidelines
for routine screening for retinopathy of prematurity.
Arch Pediatr
Med
2001;
155:
387-395
.
22. Ungar A, Bouverot P. The ventilatory responses of conscious dogs to isocapnic oxygen tests: a method of exploring the central component of respiratory drive and its dependence on O2 and CO2. Respir Physiol 1980; 39: 183-197 [Medline].
23. Mortola JP, Frappell PB, Dotta A, Matsuoka T, Fox G, Weeks S, Mayer D. Ventilatory and metabolic responses to acute hyperoxia in newborns. Am Rev Respir Dis 1992; 146: 11-15 [Medline].
24. Calder NA, Williams BA, Smith J, Boon AW, Kumar P, Hanson MA. Absence of ventilatory responses to alternating breaths in mild hypoxia and air in infants who have had bronchopulmonary dysplasia: implications for the risk of sudden infant death. Pediatr Res 1994; 35: 677-681 [Medline].
25.
Ledlie JF,
Kelsen SG,
Cherniack S,
Fishman AP.
Effects of hypercapnia
and hypoxia on phrenic nerve activity and respiratory timing.
J Appl
Physiol
1981;
51:
732-738
26. Katz-Salamon M, Eriksson M, Jonsson B. Development of peripheral chemoreceptor function in infants with chronic lung disease and initially lacking hyperoxic response. Arch Dis Child 1996; 126: 887-891 .
27. Thomas DA, Poole K, McArdle EK, Beardsmore CS, Goodenough PC, Thompson PC, Simpson H. Peripheral chemoresponses in infants measured by minimally invasive method utilizing two-breath alternation in FIO2. Eur Respir J 1996; 9: 1261-1268 [Abstract].
28. Thomas DA, Swaminathan S, Beardsmore CS, Mcardle EK, Macfadyen UM, Goodenough PC, Carpenter R, Simpson H. Comparison of peripheral chemoreceptor responses in monozygotic and dizygotic twin infants. Am Rev Respir Dis 1993; 148: 1605-1609 [Medline].
29. Gaultier C. Development of the control of breathing: implications for sleep-related breathing disorders in infants. Sleep 2000; 23: S136-S139 .
This article has been cited by other articles:
![]() |
B. Fauroux and A. Clement Requisite for stringent control of oxygen therapy in the neonatal period Eur. Respir. J., January 1, 2007; 29(1): 4 - 5. [Full Text] [PDF] |
||||
![]() |
K. Chardon, V. Bach, F. Telliez, V. Cardot, P. Tourneux, A. Leke, and J.-P. Libert Effect of caffeine on peripheral chemoreceptor activity in premature neonates: interaction with sleep stages J Appl Physiol, June 1, 2004; 96(6): 2161 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 333 - 344. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |